Ginkgo Biloba: How Supportive is the Data? episode artwork

EPISODE · Jun 16, 2008 · 12 MIN

Ginkgo Biloba: How Supportive is the Data?

from Clinician's Roundtable

Host: Leslie P. Lundt, MD Guest: Jeffrey Kaye, MD Patients around the world looking for the Holy Grail in staving off cognitive impairment have been using ginkgo biloba for years, to the tune of $1 billion in annual sales worldwide. How strong is the data to support this use? Dr. Jeffrey Kaye, director of the National Institute on Aging's Layton Aging and Alzheimer's Disease Center and the Oregon Center for Aging and Technology at Oregon Health and Sciences University, joins host Dr. Leslie Lundt to review key points of current research on ginkgo biloba.

Episode metadata supplied by the publisher feed · Published Jun 16, 2008

Embed this episode

NOW PLAYING

Ginkgo Biloba: How Supportive is the Data?

0:00 12:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Clinician's Roundtable?

This episode is 12 minutes long.

When was this Clinician's Roundtable episode published?

This episode was published on June 16, 2008.

Can I download this Clinician's Roundtable episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!